Skip to main content
search

Early Clinical

Sign up

Latest resources

Featured resource

Upcoming early clinical webinars

Latest early clinical blogs

Meet our experts at the following events

Conference

ICoP 2026 India

January 28 - 31, 2026
Conference

MVA Oncology Network

February 4, 2026
Conference

16th Annual World ADC London 2026

February 23 - 26, 2026

All early clinical resources

Case Studies Addressing Human Pharmacokinetic Uncertainty Using a Combination of Pharmacokinetic Simulation and Alternative First-in-human

Modeling and Simulation - PK/PD, pre-update, Publication

Application of PBPK Modeling in Drug Discovery and Development at Pfizer

Model Informed Drug Development, pre-update, Publication

γ-hydroxybutyrate Blood/Plasma Partitioning: Effect of Physiologic pH on Transport by Monocarboxylate Transporters

Model Informed Drug Development, pre-update, Publication

ST Analysis of the Fetal Electrocardiogram in Intrapartum Fetal Monitoring: A Meta-analysis

Model Informed Drug Development, pre-update, Publication

Exposure-response Relationship of AMG 386 in Combination with Weekly Paclitaxel in Recurrent Ovarian Cancer and Its Implication for Dose Selection

Model Informed Drug Development, Modeling and Simulation - PK/PD, Oncology/Hematology, pre-update, Therapeutic Specialties, Publication

Influence of Mild and Moderate Hepatic Impairment on Axitinib Pharmacokinetics

Model Informed Drug Development, pre-update, Publication

Effect of Microgravity on the Pharmacokinetics of Ibuprofen in Humans

Model Informed Drug Development, pre-update, Publication

Application of a Systems Approach to the Bottom-up Assessment of Pharmacokinetics in Obese Patients: Expected Variations in Clearance

Model Informed Drug Development, pre-update, Publication

Reducing Systems Biology to Practice in Pharmaceutical Company Research: Selected Case Studies

Model Informed Drug Development, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, NLME (Non-Linear Mixed Effects), pre-update, Publication

The Proton Pump Inhibitor, Omeprazole, but not Lansoprazole or Pantoprazole, is a Metabolism-dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel

Model Informed Drug Development, pre-update, Publication

Pharmacokinetics of Voriconazole Administered Concomitantly with Fluconazole and Population-based Simulation for Sequential Use

Model Informed Drug Development, pre-update, Publication

Effect of Different Durations and Formulations of Diltiazem on the Single-dose Pharmacokinetics of Midazolam: How Long Do We Go?

Model Informed Drug Development, pre-update, Publication
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.